Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Hamad

Showing results (101-110 of 139) with videos related to

Pageof 14
Sort By:
Pharmaceuticals (Basel, Switzerland)|November 27, 2024
Fabrication of an In Situ pH-Responsive Raloxifene-Loaded Invasome Hydrogel for Breast Cancer Management: In Vitro and In Vivo EvaluationHanan O Farouk, Marwa M Nagib, Amr Gamal Fouad, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 2, 2025
Unraveling the therapeutic landscape of miRNAs in pancreatic cancerZeinab A El-Moaty, Maria Wagdy Wasef, Yara A Elsayed, et al.
Tissue & Cell|February 11, 2026
FOXO3a-mediated structural and cellular remodeling in liver tissue: Implications for apoptosis and homeostasisHeba Ibrahim Abd El-Moaty, Sameh Saber, Rabab S Hamad, et al.
International Journal of Clinical Oncology|August 21, 2025
Targeting miRNAs in renal cell carcinoma: emerging therapeutic strategiesRabab S Hamad, Ghadir A Sayed, Mai A Abd-Elmawla, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 12, 2025
Modulation of FOXO3a Nuclear Localization by Linagliptin (BI-1356) reveals a new therapeutic target in chronic ulcerative colitisAbdulaziz Saad Alshahrani, Sameh Saber, Ohoud Shafi Alruwaili, et al.
Tissue & Cell|June 1, 2026
Engineering stem cell morphology and tissue architecture through nano-engineered materialsRabab S Hamad, Sameh Saber, Elsayed A Elmorsy, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 4, 2025
A Systems Biology Perspective on Childhood ADHD: Neurochemical Dysregulation, Brain-Behavior Interactions, and Emerging TherapeuticsNorah Suliman Alsoqih, Elsayed A Elmorsy, Rasha Abu-Khudir, et al.
Tissue & Cell|March 7, 2026
The nano-biointerface as a structural regulator of cell behavior: Interactions of extracellular vesicles, synthetic nanocarriers, and nanofibers with cellsRabab S Hamad, Sameh Saber, Alshaimaa A Farrag, et al.
IUBMB Life|April 8, 2026
Deciphering the Angiogenic Switch: The Role of miRNAs in Breast CancerHeba Ibrahim Abd El-Moaty, Ahmed S Doghish, Shaza H Aly, et al.
European Journal of Pharmacology|January 25, 2026
Reprogramming lysosomal-purinergic crosstalk governs the synergistic attenuation of NLRP3 inflammasome activation by cyclodextrin-P2X7 blockade in diabetic ratsElsayed A Elmorsy, Manal Mohamed Hatem, Hamad Alsaykhan, et al.
Pageof 14

Showing results (101-110 of 139) with videos related to

Sort By:
Pageof 14
Pharmaceuticals (Basel, Switzerland)|November 27, 2024
Fabrication of an In Situ pH-Responsive Raloxifene-Loaded Invasome Hydrogel for Breast Cancer Management: In Vitro and In Vivo EvaluationHanan O Farouk, Marwa M Nagib, Amr Gamal Fouad, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 2, 2025
Unraveling the therapeutic landscape of miRNAs in pancreatic cancerZeinab A El-Moaty, Maria Wagdy Wasef, Yara A Elsayed, et al.
Tissue & Cell|February 11, 2026
FOXO3a-mediated structural and cellular remodeling in liver tissue: Implications for apoptosis and homeostasisHeba Ibrahim Abd El-Moaty, Sameh Saber, Rabab S Hamad, et al.
International Journal of Clinical Oncology|August 21, 2025
Targeting miRNAs in renal cell carcinoma: emerging therapeutic strategiesRabab S Hamad, Ghadir A Sayed, Mai A Abd-Elmawla, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 12, 2025
Modulation of FOXO3a Nuclear Localization by Linagliptin (BI-1356) reveals a new therapeutic target in chronic ulcerative colitisAbdulaziz Saad Alshahrani, Sameh Saber, Ohoud Shafi Alruwaili, et al.
Tissue & Cell|June 1, 2026
Engineering stem cell morphology and tissue architecture through nano-engineered materialsRabab S Hamad, Sameh Saber, Elsayed A Elmorsy, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 4, 2025
A Systems Biology Perspective on Childhood ADHD: Neurochemical Dysregulation, Brain-Behavior Interactions, and Emerging TherapeuticsNorah Suliman Alsoqih, Elsayed A Elmorsy, Rasha Abu-Khudir, et al.
Tissue & Cell|March 7, 2026
The nano-biointerface as a structural regulator of cell behavior: Interactions of extracellular vesicles, synthetic nanocarriers, and nanofibers with cellsRabab S Hamad, Sameh Saber, Alshaimaa A Farrag, et al.
IUBMB Life|April 8, 2026
Deciphering the Angiogenic Switch: The Role of miRNAs in Breast CancerHeba Ibrahim Abd El-Moaty, Ahmed S Doghish, Shaza H Aly, et al.
European Journal of Pharmacology|January 25, 2026
Reprogramming lysosomal-purinergic crosstalk governs the synergistic attenuation of NLRP3 inflammasome activation by cyclodextrin-P2X7 blockade in diabetic ratsElsayed A Elmorsy, Manal Mohamed Hatem, Hamad Alsaykhan, et al.
Pageof 14